Archive | SIRION Biotech GmbH

Home / Archive

SIRION Biotech licenses adenovirus technology to Danish start-up InProTher in vaccine approach to cancer

SIRION Biotech licenses adenovirus technology to Danish start-up InProTher in vaccine approach to cancer

Monday 17th February 2020

By SIRION Biotech… Learn More >

SIRION Biotech aims for IPO public share offering

SIRION Biotech aims for IPO public share offering

Thursday 30th January 2020

By SIRION Biotech… Learn More >

Molecular biologist Dr. Carl Christel to head SIRION Biotech in USA

Molecular biologist Dr. Carl Christel to head SIRION Biotech in USA

Tuesday 12th November 2019

By SIRION Biotech… Learn More >

SIRION Biotech participates in combined ABC of AAV offer at ESGCT 2019 Barcelona

Friday 11th October 2019

By SIRION Biotech… Learn More >

RNAiONE™ algorithmic identification of shRNA sequences

Monday 30th September 2019

By SIRION Biotech… Learn More >

SIRION records 100% revenue growth

Friday 30th August 2019

By SIRION Biotech… Learn More >

Engineered lentiviral vectors for custom cell models

Monday 29th July 2019

By SIRION Biotech… Learn More >

SIRION highlights France as leading force in gene and cell therapy

Friday 28th June 2019

By SIRION Biotech… Learn More >

NIAID allergy institute chooses SIRION LentiBOOST™ technology to strengthen SCID-X1 immunodeficiency study

Tuesday 25th June 2019

By SIRION Biotech… Learn More >

SIRION Biotech Expands North American Presence by Opening New Site at Cambridge, MA.

Friday 1st March 2019

By SIRION Biotech… Learn More >

SIRION Biotech strengthens USA links with new partnership and manufacturing site

Thursday 24th January 2019

By SIRION Biotech… Learn More >

New success for SIRION Biotech vaccination candidate Ad19a/64

Monday 12th December 2016

By SIRION Biotech… Learn More >